Asia Pacific Structural Heart Closure Device Market Snapshot
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions, the expanding availability of advanced and cost-efficient device options, and mounting clinical evidence, which will particularly propel the LAA closure device segment. However, pricing pressures—now intensified under China’s VBP program—will continue to constrain ASPs and influence competitive dynamics across the region.
Read our Market Snapshot to access comprehensive data and analysis on the state of the structural heart closure device market in the Asia Pacific from 2019 through 2034.
![]()